Ondine Biomedical, Inc.LSE: OBI

Result of AGM and Voting Results

· Issued by Ondine Biomedical, Inc.

Ondine Biomedical Inc.

("Ondine Biomedical", "Ondine" or the "Company")

Result of AGM and voting results

Ondine Biomedical (AIM: OBI) announces that at its Annual General Meeting held on 28 June 2024 all resolutions were duly passed.

The voting results of the AGM were as follows:

In Favor

Against

Withheld

Resolution

Votes

%

Votes

%

Votes

1. Election of Directors

Carolyn Cross

191,380,245

100.00

0

0.00

0

Nicolas G. Loebel

191,380,245

100.00

0

0.00

0

Jean Charest

190,741,872

99.67

0

0.00

638,373

Jean Duvall

190,741,872

99.67

0

0.00

638,373

Junaid Bajwa

190,741,872

99.67

0

0.00

638,373

Michael Farrar

190,741,872

99.67

0

0.00

638,373

Craig Tooman

190,741,872

99.67

0

0.00

638,373

2. Appointment of Auditors

191,380,245

100.00

0

0.00

0

Enquiries:

​

Ondine Biomedical Inc.       

Carolyn Cross, CEO 

+001 (604) 665 0555

Singer Capital Markets
(Nominated Adviser and Joint Broker)

Aubrey Powell, Sam Butcher, Jalini Kalaravy

+44 (0)20 7496 3000

RBC Capital Markets (Joint Broker)

Rupert Walford, Kathryn Deegan

+44 (0)20 7653 4000

Vane Percy & Roberts (Media Contact)

Simon Vane Percy, Amanda Bernard

+44 (0)77 1000 5910

About Ondine Biomedical Inc.

Ondine Biomedical Inc. is a clinical Canadian life sciences company and leader in light-activated antimicrobial therapies (also known as 'photodisinfection'). Ondine has a pipeline of investigational products, based on its proprietary photodisinfection technology, in various stages of development.

Ondine's nasal photodisinfection system has a CE mark in Europe, the UK-CA mark, and is approved in Canada and several other countries under the name Steriwave®. In the US, it has been granted Qualified Infectious Disease Product designation and Fast Track status by the FDA and is currently undergoing clinical trials for regulatory approval. Products beyond nasal photodisinfection include therapies for a variety of medical indications such as chronic sinusitis, ventilator-associated pneumonia, burns and other indications.